임상시험 트래커
추적 기업 30곳의 임상 6,982건 (국내 전체 이력 · 글로벌 진행 중). 출처: ClinicalTrials.gov
기업
24건 표시
- 2상모집 예정· Lung Cancer (NSCLC)절제 가능한 고PD-L1 비소세포폐암에 대한 수술 전후 세미플리맙 투여
Perioperative Cemiplimab for Resectable Non-Small Cell Lung Cancer With High PD-L1
협력: 리제네론
- 2상모집 예정· Ebola Virus Disease건강한 지원자에서 인마젭 투여와 에르베보 백신 접종 사이의 시간 간격이 백신 면역반응에 미치는 영향
Impact of Delay Between Administration of Inmazeb Administration and Vaccination by Ervebo on Vaccine Immune Response on Healthy Volunteers
협력: 리제네론
- 3상모집 예정· Venous Thromboembolism (VTE)Venous Thromboembolism (VTE) Prophylaxis With REGN7508 and REGN9933 in Adult and Adolescent Participants With a Peripherally Inserted Central Catheter (PICC)
리드: 리제네론
- 단계 미표기모집 예정· Conjunctivitis AllergicA Study to Identify and Characterize Adults and Pediatric Participants With Cat and/or Birch Allergy
리드: 리제네론
- 1/2상모집 예정· Ovarian CancerSafety and Efficacy of Ubamatamab With First-line Chemotherapy in Ovarian Cancer
협력: 리제네론
- 3상모집 예정· Atrial Fibrillation (AF)Stroke and Systemic Embolism Prevention in Adult Participants With Atrial Fibrillation
리드: 리제네론
- 3상모집 예정· Fibrodysplasia Ossificans Progressiva (FOP)A Study to Investigate the Safety, Pharmacokinetics (PK), and Efficacy of Garetosmab in Children and Adolescents With Fibrodysplasia Ossificans Progressiva (FOP)
리드: 리제네론
- 2상모집 예정· Overweight or ObesityStudy of Olatorepatide in Adult Participants Living With Overweight or Obesity Without Diabetes
리드: 리제네론
- 1/2상모집 예정· Primary Open Angle Glaucoma (POAG)REGN22530 for Adults With Primary Open Angle Glaucoma or Ocular Hypertension
리드: 리제네론
- 4상모집 예정· Relapsed/Refractory Multiple Myeloma (RRMM)Adult Outpatient Linvoseltamab With Tocilizumab Prophylaxis to Mitigate the Risk of Cytokine Release Syndrome (CRS)
리드: 리제네론
- 2상모집 예정· Metabolic Dysfunction-Associated Steatohepatitis (MASH)Study to Evaluate ALN-CIDEB in Adults With Fibrotic Metabolic Dysfunction-Associated Steatohepatitis (MASH)
리드: 리제네론
- 2상모집 예정· Bladder Urothelial CarcinomaA Study of Radiation Therapy and Cemiplimab With or Without Fianlimab In People With Bladder Cancer
협력: 리제네론
- 1상모집 예정· Hepatocellular CarcinomaCemiplimab +/- Fianlimab Post Y90 Radioembolization in Patients With Hepatocellular Carcinoma
협력: 리제네론
- 1상모집 예정· Nasopharyngeal CarcinomaA Study of Cemiplimab and Fianlimab in People With Nasopharyngeal Carcinoma
협력: 리제네론
- 4상모집 예정· Chronic Obstructive Pulmonary Disease (COPD)This After Market Study is Seeing if Dupilumab Plus Usual Standard of Care (SOC) is Better Than Usual Care Alone for Adult Participants After a Severe Chronic Obstructive Pulmonary Disease (COPD) Flare-Up Requiring Hospitalization
리드: 리제네론 · 협력: 사노피
- 1/2상모집 예정· Metastatic Castration-Resistant Prostate Cancer (mCRPC)REGN15505 (PSMAx4-1BB) Alone or in Combination With Cemiplimab or REGN4336 (PSMAxCD3) in Adult Patients With Metastatic Castration-Resistant Prostate Cancer and Clear Cell Renal Cell Carcinoma
리드: 리제네론
- 3상모집 예정· Chronic Rhinosinusitis With Nasal PolypsA Phase 3 Study to Assess the Efficacy, Safety, and Tolerability of Itepekimab (Anti-IL-33 mAb) in Adult Japanese Participants With Inadequately-controlled Chronic Rhinosinusitis With Nasal Polyps
리드: 사노피 · 협력: 리제네론
- 2상모집 예정· Pleural MesotheliomasTrial Assessing Fianlimab Plus Cemiplimab Plus Chemotherapy or Cemiplimab Plus Chemotherapy in Patients With Pleural Mesothelioma
협력: 리제네론
BioPulse가 제공하는 정보는 공개된 자료를 요약·정리한 것으로, 투자 조언이나 의료 조언이 아닙니다. 임상 데이터·규제 일정·공시 내용은 반드시 원문을 직접 확인하시기 바랍니다.